People with Chorea Can Switch from Xenazine To Austedo Safely, Phase 3 Clinical Trial Shows
Jul 13, 2017 12:07 pm | Joana Fernandes, PhD
Huntington’s patients who are taking Xenazine for the twitching condition known as chorea can switch without concern to the newly approved Austedo, according to Austedo’s maker, Teva Pharmaceutical Industries. A Phase 3 clinical trial showed that the switch was safe and that Austedo (deutetrabenazine) did a better job of controlling chorea than Lundberg Pharmaceuticals‘ Xenazine (tetrabenazine), Teva said. Teva […]
The post People with Chorea Can Switch from Xenazine To Austedo Safely, Phase 3 Clinical Trial Shows appeared first on Huntington's Disease News.